These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected. Ren Y, Dai C, Shen J, Liu Y, Xie D, Zheng H, He J, Liang W, Jiang G, Fei K, Yang P, He J, Chen C. Oncotarget; 2016 May 03; 7(18):26856-65. PubMed ID: 27057627 [Abstract] [Full Text] [Related]
4. In lung cancer patients where a malignant pleural effusion is found at operation could resection ever still be justified? Fiorelli A, Santini M. Interact Cardiovasc Thorac Surg; 2013 Aug 03; 17(2):407-12. PubMed ID: 23656925 [Abstract] [Full Text] [Related]
7. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma. Yanagawa N, Shiono S, Abiko M, Abe M, Watanabe K, Watanabe I, Uematsu M, Ogata SY, Sato T, Tamura G. Interact Cardiovasc Thorac Surg; 2014 May 03; 18(5):621-5. PubMed ID: 24532312 [Abstract] [Full Text] [Related]
8. Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study. Li H, Sun Z, Yang F, Sui X, Liu T, Wang J. Eur J Cardiothorac Surg; 2019 Jun 01; 55(6):1121-1129. PubMed ID: 30726889 [Abstract] [Full Text] [Related]
9. Survival of M1a Non-Small Cell Lung Cancer Treated Surgically: A Retrospective Single-Center Study. Liu T, Liu H, Wang G, Zhang C, Liu B. Thorac Cardiovasc Surg; 2015 Oct 01; 63(7):577-82. PubMed ID: 25893920 [Abstract] [Full Text] [Related]
11. Surgical choice of non-small cell lung cancer with unexpected pleural dissemination intraoperatively. Hu J, Chen Y, Zhu X, Ma Q, Zhang J, Jiang G, Zhang P. BMC Cancer; 2021 Apr 22; 21(1):445. PubMed ID: 33888088 [Abstract] [Full Text] [Related]
12. Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology. Nakao M, Hoshi R, Ishikawa Y, Matsuura Y, Uehara H, Mun M, Nakagawa K, Okumura S. Interact Cardiovasc Thorac Surg; 2015 Jun 22; 20(6):777-82. PubMed ID: 25762707 [Abstract] [Full Text] [Related]
15. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: is tumor resection beneficial for prognosis? Sawabata N, Matsumura A, Motohiro A, Osaka Y, Gennga K, Fukai S, Mori T, Japanese National Chest Hospital Study group for Lung Cancer. Ann Thorac Surg; 2002 Feb 22; 73(2):412-5. PubMed ID: 11845851 [Abstract] [Full Text] [Related]
16. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients. Enatsu S, Yoshida J, Yokose T, Nishimura M, Nishiwaki Y, Shirakusa T, Nagai K. Ann Thorac Surg; 2006 Jan 22; 81(1):298-304. PubMed ID: 16368385 [Abstract] [Full Text] [Related]
17. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S. J Thorac Cardiovasc Surg; 2013 Aug 22; 146(2):372-8. PubMed ID: 23870323 [Abstract] [Full Text] [Related]
18. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection. Liu W, Shao Y, Guan B, Hao J, Cheng X, Ji K, Wang K. Int J Clin Exp Pathol; 2015 Aug 22; 8(9):11268-77. PubMed ID: 26617851 [Abstract] [Full Text] [Related]
19. Surgical treatment of primary lung cancer with synchronous brain metastases. Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC. J Thorac Cardiovasc Surg; 2001 Sep 22; 122(3):548-53. PubMed ID: 11547308 [Abstract] [Full Text] [Related]